The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy.
Alessandro LoglioMassimo IavaroneFloriana FacchettiDhanai Di PaoloRiccardo PerbelliniGiovanna LunghiFerruccio CeriottiClaudio GalliMaria T SandriMauro ViganòAngelo SangiovanniMassimo ColomboPietro LamperticoPublished in: Liver international : official journal of the International Association for the Study of the Liver (2020)
Combination of PIVKA-II and AFP increases the detection rate for HCC in NUC-treated HBV Caucasian cirrhotics, a potential new approach for surveillance.